The University of New Mexico Hospital is procuring a one‑year subscription to the RapidAI clinical‑imaging software platform to support stroke and neurovascular diagnostics. The software provides automated image analysis, scoring tools, and real‑time communication features that are fully integrated with UNMH’s PACS and radiology workflow. Because RapidAI is a proprietary, FDA‑cleared solution already in use at UNMH, the solicitation was awarded as a sole‑source contract. The agreement is for $75,400 for the first year, with the possibility of future license additions and renewal under state law.
• Proprietary clinical‑imaging software (RapidAI) for stroke, CT/MR perfusion, and ICH detection.
• One‑year firm‑fixed‑price subscription ($75,400) with renewal option.
• Sole‑source justification based on unique expertise, existing integration, and patient‑care risk.